Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

Androgens and prostate disease.

Cooper LA, Page ST.

Asian J Androl. 2014 Mar-Apr;16(2):248-55. doi: 10.4103/1008-682X.122361.

PMID:
24407178
[PubMed - in process]
Free PMC Article
2.

Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer.

Chiang AS, Loblaw DA, Jethava V, Sethukavalan P, Zhang L, Vesprini D, Mamedov A, Nam R, Klotz L.

Can Urol Assoc J. 2013 Nov-Dec;7(11-12):450-3. doi: 10.5489/cuaj.262.

PMID:
24381668
[PubMed]
Free PMC Article
3.

Preventive and therapeutic efficacy of finasteride and dutasteride in TRAMP mice.

Opoku-Acheampong AB, Unis D, Henningson JN, Beck AP, Lindshield BL.

PLoS One. 2013 Oct 18;8(10):e77738. doi: 10.1371/journal.pone.0077738. eCollection 2013.

PMID:
24204943
[PubMed - in process]
Free PMC Article
4.

Cancer chemoprevention: a rapidly evolving field.

Steward WP, Brown K.

Br J Cancer. 2013 Jul 9;109(1):1-7. doi: 10.1038/bjc.2013.280. Epub 2013 Jun 4. Review.

PMID:
23736035
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Insulin-like growth factors and insulin-like growth factor-binding proteins and prostate cancer risk: results from the prostate cancer prevention trial.

Neuhouser ML, Platz EA, Till C, Tangen CM, Goodman PJ, Kristal A, Parnes HL, Tao Y, Figg WD, Lucia MS, Hoque A, Hsing AW, Thompson IM, Pollak M.

Cancer Prev Res (Phila). 2013 Feb;6(2):91-9. doi: 10.1158/1940-6207.CAPR-12-0250. Epub 2013 Jan 11.

PMID:
23315596
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1).

Mayhoub AS, Marler L, Kondratyuk TP, Park EJ, Pezzuto JM, Cushman M.

Bioorg Med Chem. 2012 Dec 15;20(24):7030-9. doi: 10.1016/j.bmc.2012.10.006. Epub 2012 Oct 23.

PMID:
23142320
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Projecting prostate cancer mortality in the PCPT and REDUCE chemoprevention trials.

Pinsky PF, Black A, Grubb R, Crawford ED, Andriole G, Thompson I, Parnes H.

Cancer. 2013 Feb 1;119(3):593-601. doi: 10.1002/cncr.27774. Epub 2012 Aug 14.

PMID:
22893105
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Does variation in either age at start of therapy or duration of therapy make chemoprevention with finasteride cost-effective?

Stewart SB, Scales CD Jr, Moul JW, Reed SD.

Prostate Cancer Prostatic Dis. 2012 Dec;15(4):380-5. doi: 10.1038/pcan.2012.26. Epub 2012 Jul 10.

PMID:
22777393
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Prostate cancers detected during 5α-reductase inhibitor use are smaller, de-differentiated, but confined when compared to controls.

Lee F, Badalament RA, Hu C, Bousho I, Tsodikov A.

J Cancer. 2012;3:122-8. doi: 10.7150/jca.4123. Epub 2012 Mar 7.

PMID:
22408685
[PubMed]
Free PMC Article
10.

In vivo imaging of intraprostatic-specific gene transcription by PET.

Pouliot F, Karanikolas BD, Johnson M, Sato M, Priceman SJ, Stout D, Sohn J, Satyamurthy N, deKernion JB, Wu L.

J Nucl Med. 2011 May;52(5):784-91. doi: 10.2967/jnumed.110.084582. Epub 2011 Apr 15.

PMID:
21498525
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic.

Meyskens FL Jr, Curt GA, Brenner DE, Gordon G, Herberman RB, Finn O, Kelloff GJ, Khleif SN, Sigman CC, Szabo E; C-Change Chemoprevention Clinical Trials and Biomarkers Subcommittee.

Cancer Prev Res (Phila). 2011 Mar;4(3):311-23. doi: 10.1158/1940-6207.CAPR-09-0014.

PMID:
21372031
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.

Goodman PJ, Tangen CM, Kristal AR, Thompson IM, Lucia MS, Platz EA, Figg WD, Hoque A, Hsing A, Neuhouser ML, Parnes HL, Reichardt JK, Santella RM, Till C, Lippman SM.

Cancer Prev Res (Phila). 2010 Dec;3(12):1523-33. doi: 10.1158/1940-6207.CAPR-09-0256.

PMID:
21149329
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Prevention strategies in prostate cancer.

Trottier G, Lawrentschuk N, Fleshner NE.

Curr Oncol. 2010 Sep;17 Suppl 2:S4-10.

PMID:
20882132
[PubMed]
Free PMC Article
14.

Molecular genetics of prostate cancer: new prospects for old challenges.

Shen MM, Abate-Shen C.

Genes Dev. 2010 Sep 15;24(18):1967-2000. doi: 10.1101/gad.1965810. Review.

PMID:
20844012
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Does Finasteride Affect the Severity of Prostate Cancer? A Causal Sensitivity Analysis.

Shepherd BE, Redman MW, Ankerst DP.

J Am Stat Assoc. 2008 Dec 1;103(484):1392-1404.

PMID:
20526381
[PubMed]
Free PMC Article
16.

The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model.

Eikenberry SE, Nagy JD, Kuang Y.

Biol Direct. 2010 Apr 20;5:24. doi: 10.1186/1745-6150-5-24.

PMID:
20406442
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The influence of hepatic function on prostate cancer outcomes after radical prostatectomy.

Bañez LL, Loftis RM, Freedland SJ, Presti JC Jr, Aronson WJ, Amling CL, Kane CJ, Terris MK.

Prostate Cancer Prostatic Dis. 2010 Jun;13(2):173-7. doi: 10.1038/pcan.2010.3. Epub 2010 Mar 2.

PMID:
20195294
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Neuhouser ML, Till C, Kristal A, Goodman P, Hoque A, Platz EA, Hsing AW, Albanes D, Parnes HL, Pollak M.

Cancer Prev Res (Phila). 2010 Mar;3(3):279-89. doi: 10.1158/1940-6207.CAPR-09-0188. Epub 2010 Feb 23.

PMID:
20179296
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.

Mostaghel EA, Geng L, Holcomb I, Coleman IM, Lucas J, True LD, Nelson PS.

Cancer Res. 2010 Feb 15;70(4):1286-95. doi: 10.1158/0008-5472.CAN-09-2509. Epub 2010 Feb 2.

PMID:
20124490
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?

Vickers AJ, Savage CJ, Lilja H.

J Clin Oncol. 2010 Mar 1;28(7):1112-6. doi: 10.1200/JCO.2009.23.5572. Epub 2010 Feb 1.

PMID:
20124185
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk